Pfizer Testing Oral Covid Treatment — Would Be First To Market

  • 📰 Forbes
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

After bringing the first vaccine to market, Pfizer hopes for the next breakthrough

a stage one clinical trial on an oral antiviral therapy that a Covid-19 patient could take when they first develop symptoms, which would make it the first oral antiviral treatment for coronavirus. ... [+]

Pfizer has been working with the company Biontech on the development of a Covid 19 vaccine. Photo: Christophe Gateau/dpa The trial is being conducted in the U.S. and relies on protease inhibitors—the same kind ofThe trial is randomized and includes placebo groups with both single and multiple-dose studies.

The company is also studying an intravenous antiviral to treat Covid-19, which is now being used on clinical trial patients hospitalized with Covid-19. “Together, the two [oral and intravenous antivirals] have the potential to create an end to end treatment paradigm that complements vaccination,” Pfizer chief scientific officer Mikael Dolsten said.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 394. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

If only they could ship vaccines properly

Isn‘t the 'Pfizer vaccine' really a product by BioNTech?

usa

I hope this vaccine won’t have effect on human in the future? I could remember how things were when the first vaccine came up with in the life of the Russian president daughter

wow

日本 最新ニュース, 日本 見出し